Prof Katya Rubia

[Prof Katya Rubia @KatyaRubia108]

A New ADHD Treatment: Is It Worth the Hype? - Roar News

[Prof Katya Rubia @KatyaRubia108]

Another article on the inefficacy of TNS for ADHD based on our study
A New ADHD Treatment: Is It Worth the Hype? - Roar News

[King's Maudsley Partnership @KingsMaudsley]

Research from @KingsIoPPN led by Professor Katya Rubia found no added benefit of trigeminal nerve stimulation for ADHD symptoms compared with a placebo condition.

Watch the webinar to learn what this means: https://t.co/fFun4ROxYD

@MaudsleyNHS @maudsleycharity

[Prof Katya Rubia @KatyaRubia108]

A very critical article on the FDA clearing and approving medical devices that are safe but not effective for patients. Based on our latest UK TNS trial of the Monarch TNS device that does not work for ADHD.
https://t.co/HrcIowk3Mk

[Prof Katya Rubia @KatyaRubia108]

Brain device for ADHD shows no benefit in major UK trial https://t.co/jzq6Hn7nvw via @ConversationUK

[Prof Katya Rubia @KatyaRubia108]

ADHD treatments move beyond stimulants https://t.co/1TLFw9y0nH

[Prof Katya Rubia @KatyaRubia108]

My research is available on @ResearchGate: https://t.co/Zd7ASdxjKG

[Samuele Cortese @CorteseSamuele]

In 2019, FDA permitted marketing of Trigeminal Nerve Stimulation (eTNS) for #ADHD. In our trial, run at @KingsCollegeLon and @unisouthampton, led by @KatyaRubia108, out in @NatureMedicine, eTNS was overall safe but not superior to the control condition.
https://t.co/hQbtPWe5PU

[Prof Katya Rubia @KatyaRubia108]

Our large rigorous multicentre UK study at @kingsioppn found that the only medical device cleared for ADHD by the FDA, trigeminal nerve stimulation, is not effective for ADHD.
https://t.co/kE5QlZSDKH.

[Prof Katya Rubia @KatyaRubia108]

Our study including 151 collaborators comparing ADHD, Anxiety, Depression, Conduct Disorder in 8780 people scanned with brain MRI at 68 sites worldwide.
https://t.co/mpZufSRjC3

[Prof Katya Rubia @KatyaRubia108]

the brain undergoes 4 dramatic turning points as shown bya a large scale cross-sectional MRI analysis between 0 and 90 years
https://t.co/Snc1LiVvbp

[Prof Katya Rubia @KatyaRubia108]

See my opinion on AI toys in newsweek; I think there are both pros and cons (as with most novel technology)

https://t.co/cizSC3CJtz

[Newsweek @Newsweek]

As AI toys make their way to American shelves, Newsweek spoke to experts about their potential impact on children. https://t.co/EM832jRW9S

[Prof Katya Rubia @KatyaRubia108]

https://t.co/nGM3UGVFaA
Our recent paper shows concerning deterioration of attention performance in kids with ADHD with Guanfacine, while improving with Lisdexamfetamine.

[Institute of Psychiatry, Psychology & Neuroscience @KingsIoPPN]

"you shouldn’t take ADHD drugs at all if you don’t have ADHD..."

Prof. @KatyaRubia108 sat down with The @Telegraph to discuss how #ADHD drugs work and their effects on the body.

Click the link to learn more 👇

#IoPPNInTheNews @NIHRMaudsleyBRC

https://t.co/xHrgCU4PE9

[Prof Katya Rubia @KatyaRubia108]

We are recruiting for a Senior Research Fellow with expertise in fNIRS at the Department of Child and Adolescent Psychiatry/Pears Maudsley Center for Young People at King's College London. The fellow will work closely with me and other teams at KCL.
https://t.co/nle7OxCubr

[Prof Katya Rubia @KatyaRubia108]

@thehealthb0t Yes thanks ! I followed his protocol for a year!

[Samuele Cortese @CorteseSamuele]

Please consider taking part in our @NIHRresearch funded study on #ADHD and #sleep. @SotonPsych @unisouthampton

[Health Research | Southampton @UHSFTresearch]

Almost 75% of children with #ADHD have sleep problems.

The DISCA study is partnering with families to help with a new app or website.

If you are a parent or carer of a child with ADHD, join our webinar to find out more.

🗓️ Tue 15th November - 10:30
👉 https://t.co/z6qP3qwNr7

[The Royal Society of Medicine @RoySocMed]

Join @RSMPsyc in this meeting to gain an in depth understanding of the effects of cannabis.

Taking place Tuesday 8 November at the Royal Society of Medicine, with key speakers Sir Robin Murray and Dr @MartaDiForti 👇

https://t.co/RlcCi3IJi9

@cannabis_and_me

[Prof Katya Rubia @KatyaRubia108]

@RoySocMed